Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed. This indicates a newer revision of the page's metadata.
    Difference
    0.0%
    Check dated 2026-05-15T15:28:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record dates show new entries for 2026-04-28 and 2026-04-29 and removals for 2026-03-03 and 2026-03-04, indicating a revision of the record on those dates.
    Difference
    0.2%
    Check dated 2026-05-01T09:22:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s footer/version label has been updated from one software revision to the next (v3.5.2 to v3.5.3), indicating a site release rather than a change to the trial record.
    Difference
    0.0%
    Check dated 2026-04-24T06:31:06.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    - Revision: v3.5.2 (updated from v3.5.0)
    Difference
    0.1%
    Check dated 2026-04-17T02:56:27.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version metadata updated to add revision v3.5.0 and remove revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T09:25:46.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T04:53:43.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.